Radiofrequency Therapy for Vaginal Health Radiofrequency Therapy for Vaginal Health Home Overview Radiofrequency therapy is a gentle, non-invasive, non-ablative laser treatment designed to enhance vaginal health and pelvic floor support. his procedure uses controlled heat to stimulate collagen production and tissue regeneration, strengthening the vaginal wall and improving symptoms of stress urinary incontinence, vaginal laxity, and genitourinary syndrome of menopause (GSM). Unlike traditional treatments, radiofrequency therapy requires no anaesthesia, causes minimal discomfort, and has no downtime, making it a convenient option for women seeking to restore comfort, confidence, and quality of life. It is particularly beneficial for women experiencing changes due to childbirth, ageing, or hormonal shifts. Uses of radiofrequency therapy Radiofrequency therapy is an effective, non-invasive treatment that addresses various gynecological and urological conditions by stimulating collagen production and improving tissue function. It offers significant benefits for women experiencing pelvic floor disorders, vaginal health concerns, and menopause-related symptoms. The following are key applications of radiofrequency therapy:Stress urinary incontinenceWorks best for mild to moderate cases of SUIHelps reduce stress-related leakage in mixed incontinence casesStrengthens urethral support by improving vaginal wall structureTargets connective tissue in the vaginal mucosa, particularly the anterior vaginal wallVaginal atrophyIdeal for women experiencing vaginal dryness, irritation, and painful intercourseUses low-energy, non-ablative therapy to gently stimulate tissue renewalImproves blood circulation and enhances tissue hydrationRestores the normal structure and function of the vaginal mucosaGenitourinary syndrome of menopauseHelps relieve urinary symptoms, such as urgency and discomfortEliminates the need for long-term oestrogen therapySignificantly improves GSM symptoms, enhancing overall comfort and well-beingVaginal relaxation syndromeIdeal for women experiencing vaginal dryness, irritation, and painful intercourseUses low-energy, non-ablative therapy to gently stimulate tissue renewalImproves blood circulation and enhances tissue hydrationRestores the normal structure and function of the vaginal mucosa Advantages of radiofrequency therapy Patient friendly and non-invasiveQuick and simple, in-office procedureOutstanding results with minimal side effectsNo anaesthesia required, as it is non-ablative treatmentMinimal discomfort or downtime, allowing a quick return to daily activities Read more about Radiofrequency Therapy for Vaginal Health Filter Alphabet R
Anti-Ageing Anti-Ageing Home Overview Ageing gracefully is always something that all men and women desire. Collagen breakdown and facial ageing is primarily controlled by our genetics. Recent advances in aesthetics have shown that epigenetics (the effects of the environment on genetics) plays a very important role in ageing.We can ensure that our skin ages well by consuming collagen-boosting foods, using topical products that encourage the stimulation of collagen, and consuming supplements that promote collagen build up. There are several treatment options available for these purposes:Monopolar and Bipolar Radio frequency treatment to stimulate collagen, for example, Thermage and UltherapyPRP therapy or vampire facialDerma penTreatment with Er:YAG (erbium-doped yttrium aluminium garnet) laser (a laser that emits infrared light and is useful for skin rejuvenation and treating ace scarring and skin pigmentation)ThreadingApplication of dermal fillersBotox injections Read more about Anti-Ageing Filter Alphabet A
Ovarian Tissue Cryopreservation (OTC) Ovarian Tissue Cryopreservation (OTC) Home Overview Ovarian tissue cryopreservation (OTC) refers to the freezing of the ovarian cortex, i.e., the outer layer of the ovary; this layer is the egg-producing layer of the ovary and often determines the fertility of women. OTC is a useful technique that is most commonly used to preserve fertility and extend childbearing years in women. However, potential applications for OTC beyond fertility preservation include cHRT and cell-/tissue-based hormone replacement therapy for treating cancers in young women and the treatment of other gynaecological conditions, such as premature ovarian insufficiency and polycystic ovary syndrome (PCOS). Why OTC? OTC and transplantation have garnered an increasing amount of attention as successful methods for preserving fertility in young women with primary malignancies; these methods offer them an opportunity to become biological mothers once they have recovered from cancer. Apart from the preservation of the reproductive potential, OTC also enables the endocrine functions of the ovaries to be restored, ultimately protecting the female reproductive cycle by promoting the secretion of natural levels of essential hormones.Given the increasing incidence of the loss of ovarian function resulting from ageing and induced primary ovarian insufficiency (POI), presently, new treatment modalities whereby the surplus of follicles that most women possess since birth can be utilised are urgently needed; this can help women conquer major health issues resulting from the deficiency of ovarian hormones. Procedure for OTC Currently, more than 20,000 girls and women worldwide have been estimated to have undergone OTC. This procedure involves the following steps:First, the ovarian tissues are laparoscopically or surgically removed, followed by freezing of the cortical tissues to yield tissue sections (thickness, approximately 1 mm). Then, the tissues are fragmented mechanically and examined histopathologically to ascertain the presence of malignant cells (and eliminate them) and assess the tissue quality (using the primordial follicle density as an indicator). Finally, the sections are frozen in small fragments.Upon the completion of anti-cancer treatment and recovery, the woman may develop ovarian insufficiency. She is then eligible for ovarian tissue transplantation, which, after tissue thawing, can be performed either orthotopically or heterotopically. This process ensures that the endocrine function is resumed and puberty is initiated.As the cortical tissues primarily contain ovarian follicles at the early stages of follicular development, these tissues require about 3–6 months to regain their full activity and functions, including the sustenance of preovulatory follicle development and the release of fertilisable oocytes. Advantages of OTC Overall, OTC is a useful technique associated with the following advantages:Prior ovarian stimulation is not required. Thus, anti-cancer treatment can be administered immediately.It ensures that the primordial follicles of the ovarian cortex are more resistant to cryoinjury than mature oocytes.A large number of primordial follicles can be cryopreserved; this increases the possibility of maintaining fertility for the entirety of the graft's lifetime and decreases the possibility of multiple IVF attempts being required for achieving pregnancy.Fertility can be preserved for a longer duration than that achieved using embryo and oocyte freezing.OTC offers protection against earlier onset of menopause. Read more about Ovarian Tissue Cryopreservation (OTC) Filter Alphabet O
Fertility Preservation Fertility Preservation Home THE BIOLOGICAL CLOCK Women are born with roughly five hundred thousand eggs; by the time a woman turns 40, this reserve is depleted. Can we halt the biological clock? The “biological clock” is directly associated with the gradual depletion of the egg supply that each woman is born with. The ticking of their ovarian biological clock, i.e., with ageing, and not knowing their position on this clock represent two of the most prominent dilemmas that women face. To address these issues, cryopreservation technology, which is rapidly manifesting as ‘fertility insurance’, is attracting widespread attention. Halting the biological clock What if it was possible to stop eggs from ageing? A 42-year-old woman could serve as her own egg donor: a gift from her 30-year-old self.For career-oriented women or women about to undergo chemotherapy, halting the biological clock is a viable option. Thus, a woman can work or recover from a specific condition and choose to conceive later. This option has finally been made possible by science owing to vitrification. Fertility preservation is indicated under the following circumstances Occurrence of malignancies for which gonadotoxic therapy (including chemotherapy, radiation, and/or surgical resection), immunotherapy, and/or bone marrow transplantation are required:Haematological malignancies (leukaemia, lymphoma, and multiple myeloma)Breast cancerSarcomasCertain pelvic cancersCentral nervous system tumoursOvarian-focussed cancer radiotherapyOncofertility is a branch of gynaecologic oncology that represents the combination of dedicated cancer and reproductive care to ensure that after cancer diagnosis, patients and/or survivors can preserve their fertility and achieve maximum reproductive potential. Oncofertility preservation involves a discussion of the effects of cancer treatment on the male/female reproductive systems and the associated risks and complications. Agents used for cytotoxic chemotherapy exert progressive, often irreversible, effects on the ovaries, causing the degeneration of the primordial follicles, loss of eggs, decrease in the levels of the anti-Müllerian hormone, and exhaustion of the ovarian follicle reserve. The type of chemotherapeutic drug used, its dosage, the duration of chemotherapy, and the age of the patient during treatment determine the extent of these effects. Radiation affects the primordial follicles, leading to early ovarian failure. Considering these adverse effects, counselling regarding the risk of infertility after cancer treatment and the appropriate methods for preserving fertility must be administered to the patients. Cryopreservation of oocytes, embryos, and/or ovarian tissues (or sperms, semen, and/or testicular tissues) represents a valuable modality for preserving reproductive potential. On the basis of specific factors, such as the age of the patient, time to initiate anticancer treatment, risk of the occurrence of early ovarian insufficiency, and the possibility of using hormones to stimulate eggs, an appropriate method for preserving fertility is suggested.Presence of non-oncological diseases:Systemic diseases for which chemotherapy, radiation therapy, and/or bone marrow transplantation are required (for example, clotting disorders)Ovarian conditions: Presence of bilateral benign tumours in the ovaries, severe and recurrent ovarian endometriosis, and/or risk of developing ovarian torsionFamily history or increased risk of developing premature ovarian insufficiencyGenetic diseases that can affect future fertility (E.g.: Turner syndrome, galactosaemia, thalassemia, sickle cell disease)Autoimmune conditions, such as systemic lupus erythematosusSocietal reasons:AgeDesire to postpone childbirth to a later stage in lifeExposure to toxic chemicals Read more about Fertility Preservation Filter Alphabet F